Lipid Screening and Dyslipidemia in Children with Congenital Heart Disease - Takeaways - MDSpire

Assessment of Lipid Levels and Dyslipidemia in Pediatric Patients with Congenital Heart Defects

By
Phillip S. Cheng
Jonathan A. Wheeler
Aaron T. Walsh
Chance R. Alvarado
Kan N. Hor
Andrew H. Tran
July 4, 2026

Pediatric Cardiology

Share

1

Dyslipidemia in childhood increases the risk of atherosclerosis and cardiovascular disease in adulthood.
2

The American Academy of Pediatrics recommends lipid screening for children at ages 9-11 and 17-21, but adherence is low.
3

Children with congenital heart disease have a higher lifetime risk of cardiovascular disease compared to those without.
4

Only 18-31% of children with congenital heart disease underwent lipid screening, depending on the cardiac diagnosis.
5

The study aims to assess lipid screening rates and dyslipidemia prevalence among children with various congenital heart defects.

Original Source(s)

Pediatric Cardiology

Lipid Screening and Dyslipidemia in Children with Congenital Heart Disease

by Phillip S. Cheng, Jonathan A. Wheeler, Aaron T. Walsh, Chance R. Alvarado, Kan N. Hor, Andrew H. Tran
July 4, 2026

Related Content

Phoenix Children's Medical Connection

International Consensus on the Evaluation and Management of : Results From a Modified Delphi Survey

Hypothalamic hamartomas (HH) are rare developmental brain lesions frequently associated with medically refractory epilepsy and complex neurobehavioral, cognitive and endocrine comorbidities.

by
August 14, 2026
2 min

Acr Open Rheumatology

Tofacitinib for Calcinosis Cutis Associated With Juvenile Dermatomyositis: An Open-Label Single-Arm Study

Phoenix Children's Medical Connection

American Epilepsy Society Clinical Practice Guideline: Infantile Epilepsy

This American Epilepsy Society (AES) practice guideline provides updated, evidence-based recommendations for the management of epilepsy in infants and children aged 1 month to <36 months.

by
August 14, 2026
2 min